|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current Assets: | ||||||||||
| Cash | ||||||||||
| Prepaid expenses | ||||||||||
| Other current assets | ||||||||||
| Due from Sponsor | ||||||||||
| Cash and cash equivalents | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total Current Assets | ||||||||||
| Other assets | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| Deferred offering costs | ||||||||||
| Total Assets | ||||||||||
| LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Advances from related party | ||||||||||
| Overallotment liability | ||||||||||
| Accrued Income Taxes | ||||||||||
| Accrued franchise tax payable | ||||||||||
| Income taxes payable | ||||||||||
| Excise tax payable attributable to redemption of common stock | ||||||||||
| Due to Sponsor | ||||||||||
| Sponsor working capital loan | ||||||||||
| Promissory note - related party | ||||||||||
| Total Current Liabilities | ||||||||||
| Deferred underwriting commission | ||||||||||
| Total Liabilities | ||||||||||
| Class A common stock subject to possible redemption; 380,875 and 5,147,934 shares issued and outstanding at redemption value of $11.63 and $10.80 per share at December 31, 2024 and 2023, respectively | ||||||||||
| Common Class A | ||||||||||
| Total class A common stock subject to possible redemption; 380,875 and 5,147,934 shares issued and outstanding at redemption value of $11.63 and $10.80 per share at December 31, 2024 and 2023, respectively | ||||||||||
| Stockholders’ deficit: | ||||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||||||||||
| Common Stock, Value, Issued | ||||||||||
| Common Class A | ||||||||||
| Common Class B | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total Stockholders’ Deficit | ||||||||||
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit |
Loading...
